Iambic Therapeutics, Inc. (IAM)
NASDAQ: IAM · Real-Time Price · USD
14.67
-1.13 (-7.15%)
At close: Oct 22, 2026, 4:00 PM EDT
14.40
-0.27 (-1.84%)
Pre-market: Oct 23, 2026, 4:02 AM EDT
Iambic Therapeutics Market Cap
Iambic Therapeutics has a market cap or net worth of $695.37 million as of October 22, 2026. It is the 12,225th most valuable company in the world and the 2,491st biggest in the United States.
Market Cap
695.37M
Enterprise Value
492.72M
1-Year Change
n/a
Global Rank
Country Rank
#2,491 United States
Category
ChartMarket Cap Chart
Since the IPO on October 15, 2026, Iambic Therapeutics's market cap has decreased from $758.41M to $695.37M, a decrease of -8.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 695.37M | -7.15% |
| Oct 21, 2026 | 748.93M | -1.31% |
| Oct 20, 2026 | 758.89M | -2.02% |
| Oct 19, 2026 | 774.53M | -31.37% |
| Oct 16, 2026 | 1.13B | 48.81% |
| Oct 15, 2026 | 758.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 790.51M |
| Apnimed | 784.95M |
| Ardelyx | 777.47M |
| Geron | 735.63M |
| Annexon | 730.83M |
| Adlai Nortye Group | 724.48M |
| OmniAb | 713.87M |
| Sagimet Biosciences | 708.73M |